-
Company Profile
Soleno Therapeutics Inc – Company Profile
Soleno Therapeutics Inc (Soleno) focuses on the development of novel therapeutics for the treatment of rare diseases. The company's lead products includes Diazoxide Choline Controlled Release (DCCR), is a tablet that include crystalline salt formulation of diazoxide. Soleno provides cosense which is a portable device that is used to measure carbon monoxide in exhaled breath. The company offers various solutions to properly diagnose, monitor and care for children. It markets its products through its network of distributors. Soleno is headquartered...
Add to Basket -
Product Insights
Prader-Willi Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Prader-Willi Syndrome (PWS) Clinical Trials Market Report Overview The Prader-Willi Syndrome (PWS) clinical trial market research report provides an overview of the PWS clinical trials scenario. The report provides top-line data relating to the clinical trials on PWS. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Net Present Value Model: Diazoxide choline CR
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Diazoxide choline CR Drug Details Diazoxide...
-
Track & Monitor
Innovation in Medical Devices: Inhalation Devices
Innovations in medical devices industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in medical devices industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – diazoxide choline CR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry diazoxide choline CR Drug Details Diazoxide choline controlled release (DCCR) is under development for...
-
Product Insights
Diagnostic and Measurement Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Diagnostic and measurement devices include devices that are used to measure pressure, flow, and volume in a patient's airway and lungs. The category also covers devices used to measure oxygen saturation in the blood. The Diagnostic and Measurement Devices pipeline market research report provides comprehensive information about the image-guided surgery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prader-Willi Syndrome (PWS) is a rare genetic disorder present at birth that results in several physical, mental, and behavioral problems. PWS is due to the lack of several genes on one of an individual’s two chromosome 15s. In most cases, there is a deletion. In remaining cases, the entire chromosome from the father is missing and there are instead two chromosome 15s from the mother (uniparental disomy). Symptoms include poor muscle tone, low levels of sex hormones, and a constant...
-
Product Insights
Prader-Willi Syndrome (PWS) Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Prader-Willi Syndrome (PWS) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Prader-Willi Syndrome (PWS) Clinical trials scenario. This report provides top line data relating to the clinical trials on Prader-Willi Syndrome (PWS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor...
-
Product Insights
Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018" provides an overview of Prader-Willi Syndrome (PWS) clinical trials scenario. This report provides top line data relating to the clinical trials on Prader-Willi Syndrome (PWS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...